About this entry
POPPINS CLINICAL is a digital therapeutic from BMotion Technologies for children aged 7 to 11 with a developmental learning disorder that includes a reading deficit. France granted it early digital coverage (PECAN) under article L. 162-1-23 by arrêté of 17 July 2026, published in the Journal officiel on 21 July 2026. Coverage runs for one year from the order taking effect (13 days after publication). It is prescribed by a physician as a complement to twice-monthly speech-language therapy. The initial exploitant forfait is EUR 435 TTC (up to three months), with a subsequent monthly forfait of EUR 38.30 TTC, capped at EUR 780 TTC per patient per year. This page is not legal or reimbursement advice; confirm the current order on Légifrance.
- App
- POPPINS CLINICAL
- Maker
- BMotion Technologies
- Country
- France
- Program
- PECAN
- Status
- PECAN active
- Indication detail
- CIM-11 6A03 developmental learning disorder; used as a complement to twice-monthly speech therapy in primary care
- Coverage effective
- 2026-08-03
- PECAN coverage ends
- 2027-08-03
- Public price
- EUR 435.00
- Arrêté date
- 2026-07-17
- Journal officiel publication
- 2026-07-21
Not legal or reimbursement advice. Confirm the current entry with the official source.